Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 8Phase NA 7Phase EARLY_PHASE1 3Phase 3 3Phase 1/2 3

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Prostatic Neoplasms 9Glioma 7Brain Neoplasms 6Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Sarcoma 3Melanoma 3Lung Neoplasms 3Glioblastoma 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroendocrine Tumors 2Neuroblastoma 2Lymphoma, Large B-Cell, Diffuse 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1

Interventions

lenvatinib 3Magnetic Resonance Spectroscopy 3pembrolizumab 2gallium 68 PSMA-11 2Sorafenib 2Radiosurgery 2Cyclophosphamide 2Biopsy 268Ga-DKFZ-PSMA-11 2spartalizumab 1semaglutide 1peginterferon alfa-2b 1gadolinium ethoxybenzyl DTPA 1folfirinox 1fluoromisonidazole 1fludarabine 1atezolizumab 1alpha-2'-deoxythioguanosine 1Radiotherapy 1Propranolol 1Nivolumab 1Microscopy, Electron 1Indocyanine Green 1Ethiodized Oil 1Doxorubicin 1Cryosurgery 1CYT-6091 1Bevacizumab 1BO-112 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Hepatocellular × Magnetic Resonance Spectroscopy × Clear all
NCT05250895 2025-03-13

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Emory University

Phase EARLY_PHASE1 Completed
9 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04310540 2024-09-19

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
42 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05111314 2023-11-07

Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma

Mayo Clinic

Phase EARLY_PHASE1 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡